Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThor Energy Regulatory News (THR)

Share Price Information for Thor Energy (THR)

Share Price is delayed by 15 minutes
Get Live Data
0.60    0.05 (9.09%)
Bid:
0.55
Ask:
0.65
Spread: 0.10 (18.182%)
Market Cap: £6.18m
THR Live PriceLast checked at - London Stock Exchange

Intraday Thor Energy Share Chart

Appendix 3B

9 Nov 2018 07:00

RNS Number : 8846G
Thor Mining PLC
09 November 2018
Β 

Friday, 9 November 2018

Β 

THOR MINING PLC

Β ("Thor" or the "Company")

Β 

Appendix 3B

Β 

The Directors of Thor Mining PLC (AIM, ASX: THR) today released the following announcement on the Australian Securities Exchange ("ASX"), as required under the listing rules of the ASX.

Β 

Enquiries:

Mick Billing

+61 (8) 7324 1935

Thor Mining PLC

ExecutiveΒ Chairman

Ray Ridge

+61 (8) 7324 1935

Thor Mining PLC

CFO/Company

Secretary

Colin Aaronson/

Richard Tonthat/ Ben Roberts

+44 (0) 207 383 5100

Β 

Grant Thornton UK LLP

Β 

Nominated Adviser

Nick Emerson

+44 (0) 1483 413 500

SI Capital Ltd

Joint Broker

David Hignell / Rob Rees / Isabella Pierre

+44Β (0)20 3861 6625Β 

Northland Capital Partners Limited

Joint Broker

Tim Blythe/ Camilla Horsfall

+44 (0) 207 138 3222

Blytheweigh

Financial PR

Updates on the Company's activities are regularly posted on Thor's website www.thormining.com, which includes a facility to register to receive these updates by email, and on the Company's twitter page @ThorMining.

AboutΒ ThorΒ MiningΒ PLC

ThorΒ MiningΒ PLCΒ (AIM,Β ASX:Β THR)Β isΒ aΒ resourcesΒ companyΒ quotedΒ onΒ theΒ AIMΒ MarketΒ ofΒ theΒ LondonΒ Stock Exchange andΒ onΒ ASXΒ in Australia.

ThorΒ holdsΒ 100%Β ofΒ the advancedΒ Molyhil tungsten project in the NorthernΒ Territory of Australia, forΒ which anΒ updated feasibility study inΒ August 2018ΒΉΒ suggestedΒ attractive returns.

ThorΒ alsoΒ holdsΒ 100%Β ofΒ theΒ PilotΒ MountainΒ tungstenΒ projectΒ inΒ NevadaΒ USAΒ whichΒ hasΒ aΒ JORCΒ 2012 Indicated andΒ InferredΒ Resources EstimateΒ²Β onΒ 2Β ofΒ theΒ 4 knownΒ deposits. The US Department of the Interior has confirmed that tungsten, the primary resource mineral at Pilot Mountain, has been included in the final list of Critical Minerals 2018.

ThorΒ isΒ alsoΒ acquiringΒ upΒ toΒ aΒ 60%Β interestΒ AustralianΒ copper developmentΒ companyΒ EnvironmentalΒ Copper RecoveryΒ SAΒ Pty Ltd,Β whichΒ inΒ turnΒ holdsΒ rightsΒ toΒ earnΒ upΒ toΒ aΒ 75%Β interestΒ inΒ theΒ mineralΒ rights andΒ claims overΒ the resourceΒ³ on the portionΒ of the historic KapundaΒ copperΒ mineΒ inΒ SouthΒ Australia recoverableΒ by way ofΒ in situ recovery.

ThorΒ hasΒ anΒ interestΒ inΒ Hawkstone MiningΒ Limited,Β anΒ AustralianΒ ASX listed company withΒ aΒ 100%Β Interest inΒ a LithiumΒ projectΒ in Arizona, USA.

Finally, Thor also holds a production royalty entitlement from the Spring Hill Gold project⁴ of:

β€’ Β A$6Β perΒ ounceΒ ofΒ goldΒ producedΒ fromΒ theΒ SpringΒ HillΒ tenementsΒ whereΒ theΒ goldΒ producedΒ isΒ soldΒ forΒ up to A$1,500Β perΒ ounce;Β and

β€’ Β A$14Β perΒ ounceΒ ofΒ goldΒ producedΒ fromΒ theΒ SpringΒ HillΒ tenementsΒ whereΒ theΒ goldΒ producedΒ isΒ soldΒ for amountsΒ overΒ A$1,500Β perΒ ounce.

Β 

Notes

ΒΉΒ ReferΒ ASXΒ andΒ AIMΒ announcementΒ ofΒ 23Β AugustΒ 2018

Β²Β ReferΒ AIMΒ announcementΒ ofΒ 22Β MayΒ 2017Β andΒ ASXΒ announcementΒ ofΒ 23Β MayΒ 2017

Β³Β ReferΒ AIMΒ announcementΒ ofΒ 10Β FebruaryΒ 2016Β andΒ ASXΒ announcementΒ ofΒ 12Β FebruaryΒ 2018

⁴ Refer AIM announcement of 26 February 2016 and ASX announcement of 29 February 2017

Β 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

Β 

New issue announcement,

application for quotation of additional securities

and agreement

Β 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12

Β 

Β 

Name of entity

Thor Mining PLC

Β 

ABN

121 117 673

Β 

We (the entity) give ASX the following information.

Β 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

Β 

1

+Class of +securities issued or to be issued

Β 

(a) Ordinary shares / CDIs

(b) Ordinary shares

Β 

Β 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

Β 

(a) Transfers of 3,078,369 from AIM listed shares on the AIM Market of the London Stock Exchange, to ASX listed CDI's, during the period 2 November 2018 to 8 November 2018.

(b) Issue of 4,960,866 Ordinary Shares as a result of options (termed warrants in the UK) exercised.

Β 

The total number of securities, listed on both AIM and ASX, is now 677,096,593 as at 9 November 2018.

Β 

Β 

3

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

This represents:

(a) Transfers between AIM listed shares on the AIM Market of the London Stock Exchange, and ASX listed CDI's.

(b) Issue of Ordinary Shares ranking pari passu with existing Ordinary Shares.

Β 

4

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

Β 

If the additional securities do not rank equally, please state:

Β· the date from which they do

Β· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

Β· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

(a) Yes.

(b) Yes.

Β 

Β 

5

Issue price or consideration

Β 

(a) N/A

(b) Β£0.012 per Ordinary Share being the exercise price of the options.

Β 

Β 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

Β 

Β 

Β 

Β 

Β 

Β 

(a) N/A

(b) The result of options exercised.

Β 

Β 

Β 

Β 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

Β 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

Yes

Β 

Β 

Β 

Β 

6b

The date the security holder resolution under rule 7.1A was passed

29 November 2017

Β 

Β 

Β 

Β 

6c

Number of +securities issued without security holder approval under rule 7.1

N/A

Β 

Β 

Β 

Β 

6d

Number of +securities issued with security holder approval under rule 7.1A

N/A

Β 

Β 

Β 

Β 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

Β 

N/A

Β 

Β 

Β 

Β 

6f

Number of securities issued under an exception in rule 7.2

(a) N/A

(b) 4,960,866 Ordinary Shares.

Β 

Β 

Β 

Β 

Β 

6g

If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

N/A

Β 

Β 

Β 

Β 

6h

If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements.

N/A

Β 

Β 

Β 

Β 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

Refer attached Annexure 1

Β 

Β 

Β 

7

Dates of entering +securities into uncertificated holdings or despatch of certificates

(a) Transfers 2 November 2018 to 8 November 2018

(b) 9 November 2018

Β 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the securities in section 2 if applicable)

163,665,798

Β 

Ordinary Shares quoted by

ASX ("THR" as CDIs) as at 9 November 2018.

9

Number and +class of all +securities not quoted on ASX (including the securities in section 2 if applicable)

Β 

Β 

Β 

Β  513,430,795

Β 

Β 

Β 

Β 

Β 

28,013,157

Β 

13,600,000

Β 

20,722,389

Β 

13,840,000

Β 

2,000,000

Β 

20,000,000

39,444,444

Β 

10,000,000

Β 

15,000,000

Β 

1,500,000

10,000,000

5,000,000

15,000,000

Β 

Ordinary Shares admitted to the AIM Market of the London Stock Exchange, as at 9 November 2018.

Β 

Unlisted Options:

1.2 pence unlisted warrants expiring 29 November 2018

1.25 pence unlisted warrants expiring 1 December 2018.

1.25 pence unlisted warrants expiring 7 April 2019.

1.25 pence unlisted warrants expiring 11 April 2019.

1.8 pence unlisted warrants

Β expiring 27 June 2019.

1.25 pence unlisted warrants expiring 26 July 2019.

1.8 pence unlisted warrants

Β expiring 28 July 2019.

5.0 pence unlisted warrants expiring 29 January 2020.

1.8 pence unlisted warrants

Β expiring 31 March 2020.

1.8 pence unlisted warrants

Β expiring 27 June 2020.

1.5 pence unlisted options expiring 2 November 2020.

4.5 pence unlisted options expiring 29 December 2020.

3.5625 pence unlisted options expiring 7 June 2021.

Β 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

No Policy

Β 

Β 

Β 

Part 2 ‑ Bonus issue or pro rata issue - Not Applicable

Β 

Β 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

Β 

34

Type of securities

(tick one)

Β 

(a)

ΓΌ

Securities described in Part 1

Β 

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Β 

Entities that have ticked box 34(a)

Β Additional securities forming a new class of securities

Β 

Β 

Tick to indicate you are providing the information or documents

Β 

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

Β 

Β 

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

Β 

Β 

37

A copy of any trust deed for the additional +securities

Β 

Β 

Β 

Entities that have ticked box 34(b)

Β 

38

Number of securities for which +quotation is sought

Β 

Β 

Β 

39

Class of +securities for which quotation is sought

Β 

Β 

Β 

40

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

Β 

If the additional securities do not rank equally, please state:

Β· the date from which they do

Β· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

Β· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Β 

Β 

Β 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

Β 

(if issued upon conversion of another security, clearly identify that other security)

Β 

Β 

Β 

Β 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the securities in clause 38)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Quotation agreement

Β 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

Β 

2 We warrant the following to ASX.

Β 

Β· The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

Β 

Β· There is no reason why those +securities should not be granted +quotation.

Β 

Β· An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

Β 

Β· Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

Β 

Β· If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

Β 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

Β 

4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Β 

Β 

Β 

Β 

Β 

Sign here: .............................. Date: 9 November 2018

(Company Secretary)

Β 

Print name: Ray Ridge

Β 

== == == == ==

Appendix 3B - Annexure 1

Β 

Calculation of placement capacity under rule 7.1 and rule 7.1A for +eligible entities

Introduced 01/08/12

Part 1

Β 

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid ordinary securities on issue 12 months before date of issue or agreement to issue

as at 8 November 2017 453,598,005

Β 

Add the following:

β€’ Number of fully paid ordinary securities issued in that 12 month period under an exception in rule 7.2

β€’ Number of fully paid ordinary securities issued in that 12 month period with shareholder approval

β€’ Number of partly paid ordinary securities that became fully paid in that 12 month period

Note:

β€’ Include only ordinary securities here - other classes of equity securities cannot be added

β€’ Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

β€’ It may be useful to set out issues of securities on different dates as separate line items

Β 

Issue - options exercised 10,000,000

(Issued 10/11/17)

Β 

Issue - options exercised 20,730,855

(Issued 13/11/17)

Β 

Issue - options exercised 10,773,161

(Issued 15/11/17)

Β 

Issue - options exercised 20,749,484

(Issued 21/11/17)

Β 

Issue - options exercised 18,113,051

(Issued 29/11/17)

Β 

Placement (30/11/17) 41,151,314

(approved 29 November 2017)

Β 

Issue - options exercised 8,472,381

(Issued 6/12/17)

Β 

Issue - options exercised 13,932,458

(Issued 18/12/17)

Β 

Issue - options exercised 6,010,827

(Issued 28/12/17)

Β 

Issue - options exercised 2,402,943

(Issued 22/01/18)

Β 

Issue - options exercised 9,247,486

(Issued 9/02/18)

Β 

Issue - options exercised 12,448,707

(Issued 14/02/18)

Β 

Issue - options exercised 6,883,280

(Issued 19/02/18)

Β 

Issue - options exercised 2,932,014

(Issued 16/03/18)

Β 

Issue - options exercised 2,904,762

(Issued 13/07/18)

Β 

Issue - options exercised 1,428,571

(Issued 27/07/18)

Β 

Issue - options exercised 451,643

(Issued 6/08/18)

Β 

Issue - options exercised 4,250,000

(Issued 2/11/18)

Β 

Issue - options exercised 4,960,866

(Issued 9/11/18)

Subtract the number of fully paid ordinary securities cancelled during that 12 month period

0

Β 

"A"

651,441,808

Β 

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

97,716,271

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period not counting those issued:

β€’ Under an exception in rule 7.2

β€’ Under rule 7.1A

β€’ With security holder approval under rule 7.1 or rule 7.4

Note:

β€’ This applies to equity securities, unless specifically excluded - not just ordinary securities

β€’ Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed

β€’ It may be useful to set out issues of securities on different dates as separate line items

Β 

Issue for consideration 1,127,580

(Issued 15/12/17)

Issue for cash 10,000,000

(Issued 30/01/18)

Grant of Unlisted Options 10,000,000

(Granted 30/01/18)

Issue for consideration 14,527,205

(Issued 5/10/18)

Β 

Β 

Β 

Β 

Β 

"C"

35,654,785

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

Β 

97,716,271

Subtract "C"

Note: number must be same as shown in Step 3

Β 

35,654,785

Total ["A" x 0.15] - "C"

62,061,486

Β [Note: this is the remaining placement capacity under rule 7.1]

Part 2

Β 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

Β 

651,441,808

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

65,144,180

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

β€’ This applies to equity securities - not just ordinary securities

β€’ Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

β€’ Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

β€’ It may be useful to set out issues of securities on different dates as separate line items

"E"

0

Β 

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

Β 

65,144,180

Subtract "E"

Note: number must be same as shown in Step 3

Β 

0

Total ["A" x 0.10] - "E"

65,144,180

Note: this is the remaining placement capacity under rule 7.1A

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCGUBDBDUGBGIC
Date   Source Headline
31st Oct 20197:00 amRNSQUARTERLY REPORT JULY TO SEPTEMBER 2019
31st Oct 20197:00 amRNSAPPENDIX 5B JULY TO SEPTEMBER 2019
29th Oct 20198:13 amRNSAppendix 3B
22nd Oct 20192:05 pmRNSSecond Price Monitoring Extn
22nd Oct 20192:00 pmRNSPrice Monitoring Extension
22nd Oct 20197:00 amRNSPlacing and Subscription
17th Oct 20195:33 pmRNSStatement re Share Price Movement
14th Oct 20197:00 amRNSReceipt of Additional Vendor Shares in Hawkstone
14th Oct 20197:00 amRNSCommencement of Drilling - Bonya Tungsten
10th Oct 20197:00 amRNSMolyhill Mineral Resource Estimate Enhanced
30th Sep 20191:05 pmRNSFinal Results
30th Sep 20197:00 amRNSHawkstone - Maiden Mineral Resource Estimate
27th Aug 20197:00 amRNSDirector Appointment
19th Aug 20199:34 amRNSLithium Results at Big Sandy - Hawkstone Mining
15th Aug 20197:00 amRNSInitial Copper Resource Estimate - Moonta Project
14th Aug 20197:49 amRNSReceipt of R&D Grant
12th Aug 20198:01 amRNSFurther High Grade Bulk Sample Assays - Molyhil
5th Aug 20197:00 amRNSASX query and response
30th Jul 20197:00 amRNSQUARTERLY REPORT APRIL TO JUNE 2019
30th Jul 20197:00 amRNSAPPENDIX 5B APRIL TO JUNE 2019
23rd Jul 201910:28 amRNSFurther Lithium Results - Hawkstone's Big Sandy
8th Jul 20197:00 amRNSAppointment of Joint Broker
5th Jul 20197:40 amRNSAppendix 3B
3rd Jul 20197:00 amRNSJervois Vanadium Project
1st Jul 20197:00 amRNSIssue of Equity
28th Jun 20199:18 amRNSFurther Lithium Results - Hawkstone's Big Sandy
28th Jun 20199:08 amRNSBonya - High Grade Tungsten Confirmed - Addendum
25th Jun 20197:00 amRNSPilot Mountain Gold Sampling
24th Jun 20197:00 amRNSBonya - High grade tungsten results confirmed
14th Jun 20199:27 amRNSPilot Mountain initial gold finding clarification
13th Jun 20197:00 amRNSResponse to ASX Price Query
10th Jun 201912:00 pmRNSPilot Mountain process sample initial gold finding
6th Jun 20197:00 amRNSHigh Grade Molyhil bulk sample assay results
28th May 20197:00 amRNSInvestor Presentation
23rd May 20199:35 amRNSResult of General Meeting
23rd May 20199:35 amRNSAppendix 3B
15th May 201912:16 pmRNSLithium Results at Hawkstone's Big Sandy Deposit
7th May 20197:00 amRNSFurther Interim Tungsten & Copper Results - Bonya
30th Apr 20198:55 amRNSNotice of GM
30th Apr 20198:29 amRNSInterim Drill Results - Bonya Tungsten
29th Apr 20197:00 amRNSAPPENDIX 5B JANUARY TO MARCH 2019
29th Apr 20197:00 amRNSQUARTERLY REPORT JANUARY TO MARCH 2019
23rd Apr 20197:00 amRNSResource Estimate Commissioned - Moonta Copper
16th Apr 20197:00 amRNSCommencement of Drilling - Bonya Tungsten
10th Apr 20199:43 amRNSAppendix 3B
2nd Apr 20198:41 amRNSKapunda Gold Recovery
27th Mar 20199:06 amRNSStrategic Australian Acquisitions and Financing
25th Mar 20191:27 pmRNSClearance for Drilling - Bonya Tungsten
8th Mar 20197:00 amRNSCopper Project Q & A - March 2019
5th Mar 20199:22 amRNSStrategic Development: Australian Copper Interests

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.